The Management of Obesity in Adults

Objectives

Qatar’s National Clinical Guideline on the Management of Obesity in Adults provides an evidence-based national framework for diagnosing, staging and managing obesity in people aged 18 years and over, principally in primary-care and outpatient settings. It aims to improve obesity-related complications, reduce future health risks, and enhance physical, mental and social well-being and quality of life through sustained, individualised care.[1][2]

• Assess obesity severity using body mass index, waist circumference where appropriate, and the Edmonton Obesity Staging System for adults with a body mass index of at least 25 kg/m², in order to guide proportionate management.[3][4][5]
• Provide management matched to disease stage, from prevention and lifestyle counselling at Edmonton Stage 0 to treatment of complications, behavioural, pharmacological and surgical options at Stages 2 and 3, and feasible intensive or palliative support at Stage 4.[5]
• Achieve and maintain clinically meaningful weight loss, generally 5–10% of initial body weight, alongside agreed weight targets, improved complications and comorbidities, and reduced future cardiovascular disease, type 2 diabetes and cancer risk.[6][7]
• Address lifestyle, dietary, physical-activity, behavioural, sleep-related, psychological and social factors, while recognising that obesity may coexist with malnutrition and eating disorders.[8][9][6]
• Use pharmacological treatment after dietary, physical-activity and behavioural approaches have been initiated and assessed for eligible patients with inadequate weight loss or a plateau, and consider endoscopic or bariatric interventions where other measures have not succeeded.[10][11][12]
• Support women of childbearing age to optimise weight before conception, prevent excessive gestational weight gain, and improve maternal and infant outcomes through person-centred obesity care.[13]

Implementation

The guideline uses a multidisciplinary, stepped-care delivery model that combines universal health promotion and primary-care support with specialist weight-management, endoscopic and bariatric services. Development was led by Qatar’s Ministry of Public Health through systematic evidence review, national stakeholder involvement and independent committee review, with recommendations adapted to the national context.[1][14][5]

• Deliver health promotion, lifestyle interventions, dietetic services, physical-activity training, nurse-led education and psychological support in primary care; provide specialist services for medicines, endoscopic interventions and bariatric or metabolic surgery.[14][5]
• Use multidisciplinary teams that may include obesity-medicine physicians, nutrition specialists, surgeons, endoscopists, nurses, dietitians, mental-health professionals and medical assistants, with composition adapted to expertise and available resources.[8]
• Conduct a focused baseline assessment covering weight and treatment history, eating and activity patterns, sleep, medicines, complications, psychological factors, social and family circumstances, and readiness to change.[15][8]
• Measure height and weight accurately, calculate body mass index, apply a consistent waist-circumference method for serial assessment, investigate suspected causes and complications, and undertake routine laboratory testing tailored by clinical findings.[15][4]
• Individualise dietary and activity plans according to clinical status, preferences, functional ability, comorbidities and social circumstances; avoid nutritionally unbalanced restrictive diets and use specialist-supervised low-energy or very-low-energy diets only within multicomponent management where clinically indicated.[16][9][17]
• Apply behavioural interventions such as goal setting, self-monitoring, problem solving, relapse prevention and social support, and assess depression, anxiety, eating disorders and obstructive sleep apnoea when indicated.[2][6]
• Refer patients with complex needs, suspected underlying causes, eating disorders, need for specialist interventions, post-bariatric problems, or inadequate primary-care outcomes to specialist care.[18][19]
• Ensure appropriately trained physicians prescribe weight-management medicines within multidisciplinary teams, discuss benefits, risks, pregnancy avoidance and discontinuation with patients, reassess treatment at least every three months, and audit and report weight-management outcomes.[11][12]
• Maintain continuity after bariatric or endoscopic procedures through primary-care registers, procedure recording, regular self-weighing, annual diet review and ongoing monitoring of complications, comorbidities and medication needs.[12][13]
• Monitor progress through early and regular reviews, including weight, waist circumference, body mass index, blood pressure, heart rate, agreed weight and non-weight outcomes, and improvement in comorbidities.[6][19]
• Use potential performance measures covering body mass index communication, risk discussion, Edmonton staging, waist measurement, referral patterns, multidisciplinary input, follow-up frequency and weight loss exceeding 10% at 6, 12 or 24 months.[20]
• Govern guideline development through a Guideline Development Group of health professionals, subject experts and patient representatives, with review by the National Clinical Guidelines and Pathways Committee; conflicts of interest are declared and reviewed by the Ministry of Public Health.[1][21][3]

Monitoring & Evaluation

The guideline combines patient-level clinical monitoring with evidence-quality processes and a small set of proposed obesity performance measures. It provides regular reassessment schedules for lifestyle and medication management, outcome audits for prescribing, and longitudinal follow-up after weight loss or bariatric intervention, but does not establish a comprehensive national reporting, surveillance, or accountability framework.[1][6][11][20]

• Apply a formal evidence hierarchy, ranging from systematic reviews and randomised controlled trials to observational evidence, expert opinion and unpublished data, and grade recommendations as A, B, C or Guideline Development Group best-practice recommendations.[21]
• Conduct systematic searches of English-language literature, critically review retrieved publications for quality, usefulness and relevance, and prioritise rigorous research and material of particular relevance to the guideline.[1][22]
• Review and update the guideline regularly to incorporate stakeholder feedback, with development and review involving the Guideline Development Group and the National Clinical Guidelines and Pathways Committee; conflict-of-interest declarations are reviewed and retained by the Ministry of Public Health.[1][21][3]
• Use accurately measured height and weight to calculate body mass index, retain the initial accurate height for later assessments, and use a consistent waist-circumference method for serial measurement in an individual patient.[15][4]
• Assess obesity severity using body mass index, waist circumference where appropriate, and the Edmonton Obesity Staging System for adults with a body mass index of at least 25 kg/m².[3][4][5]
• Monitor obesity-related risk factors and health status at Edmonton Stage 1, and assess and manage complications and comorbidities closely, including intensive management where required, at Stages 2 and 3.[5]
• Document weight history, previous interventions, their outcomes and lessons learned as part of baseline and routine focused assessment.[8]
• Assess eating patterns, psychological factors, depression and anxiety using validated tools where appropriate, and refer to mental-health services when assessment identifies high scores or suspected eating disorders.[2][6]
• Review progress towards agreed weight and non-weight outcomes, dietary intake, physical activity, readiness to change, and transition from active weight loss to maintenance.[2][16]
• Review patients after two to four weeks initially, monthly for three months, and then every three months during the first year, with more frequent review for individualised programmes when needed.[6]
• Measure weight, waist circumference, body mass index, blood pressure and heart rate at each review, and assess achievement through weight-loss maintenance, agreed targets, improved complications or comorbidities, and reduced future obesity-related risk.[6][7]
• Provide three-monthly primary-care reviews for two years after weight loss has been achieved, alongside long-term multidisciplinary continuity of care and reinforcement of behavioural strategies.[7]
• Use short- and long-term goals, including mobility and self-esteem, with regular self-weighing and targets tailored to individual complications and risks.[19]
• Consider referral where weight loss remains below 5% of initial body weight or weight has increased despite active intervention over the preceding six months.[18]
• Reassess patients receiving weight-management medication at least every three months, or more often according to the medicine, complications and comorbidities; monitor treatment effects and reinforce lifestyle advice.[14][11]
• Conduct and report an audit of weight-management outcomes for prescribing practice, and continue pharmacological treatment beyond three months only where at least 5% of initial body weight has been lost, subject to clinically appropriate less stringent goals for some patients with type 2 diabetes or relevant comorbidities.[11][12]
• Maintain a primary-care register of bariatric and endoscopic surgery patients, record procedure type, encourage self-weighing, and support annual body mass index, diet and blood-test reviews after surgery.[12][13]
• Provide continuing professional follow-up after bariatric or endoscopic procedures, as long-term outcomes depend on ongoing support and monitoring.[12]
• Use eight potential performance measures covering communication of body mass index and related risks, recording Edmonton Obesity Staging System scores, waist measurement, specialist referral for Stages 2 to 4, referral to a non-physician professional within three months, primary-care follow-up at least four times annually, and weight loss exceeding 10% at 6, 12 or 24 months after diagnosis.[20]
• Define these measures through numerators and denominators for adult populations meeting specified body mass index, staging, follow-up or diagnostic criteria.[20]

The material does not specify a national data-collection system, mandatory reporting pathway, routine surveillance timetable, evaluation methodology for implementation, or named body accountable for performance beyond the guideline-development committees, prescribing audit and primary-care registers.[11][12][20]

Costing & Financing

No costed implementation plan, budget, financing source, resource-mobilisation arrangement, funding gap, or quantified economic assumption is specified.[1][13][20]

• Recognise that obesity is associated with increased hospital admissions, longer hospital stays, greater healthcare costs and higher prescription-medication costs.[23][24]
• Provide primary-care and specialist inputs, including multidisciplinary teams, dietetic services, physical-activity support, psychological care, pharmacological treatment, endoscopic procedures and bariatric surgery, but without associated resource estimates or funding allocations.[5][8][11][12]
• Plan follow-up, audits, registers and performance measurement as service requirements, while noting that the guideline does not quantify their costs or identify how they will be financed.[11][12][20]